These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 142841)

  • 61. Lymphocyte subpopulations in Down's syndrome: high percentage of circulating HNK-1+, Leu 2a+ cells.
    Maccario R; Ugazio AG; Nespoli L; Alberini C; Montagna D; Porta F; Bonetti F; Burgio GR
    Clin Exp Immunol; 1984 Jul; 57(1):220-6. PubMed ID: 6235075
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Down's syndrome and leukemia: epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis.
    Fong CT; Brodeur GM
    Cancer Genet Cytogenet; 1987 Sep; 28(1):55-76. PubMed ID: 2955886
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Acute megakaryoblastic leukemia associated with mosaic Down's syndrome.
    Simon JH; Tebbi CK; Freeman AI; Brecher ML; Green DM; Sandberg AA
    Cancer; 1987 Nov; 60(10):2515-20. PubMed ID: 2959356
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Alopecia areata, autoimmunity, and Down's syndrome.
    Du Vivier A; Munro DD
    Br Med J; 1975 Jan; 1(5951):191-2. PubMed ID: 122906
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Immunological and purine enzyme studies on hyperuricaemic and normouricaemic patients with Down's syndrome.
    Watts RW; Perera YS; Allsop J; Newton C; Platts-Mills TA; Webster AD
    Clin Exp Immunol; 1979 Jun; 36(3):355-63. PubMed ID: 158448
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Abnormal serum IgG subclass pattern in children with Down's syndrome.
    Annerén G; Magnusson CG; Lilja G; Nordvall SL
    Arch Dis Child; 1992 May; 67(5):628-31. PubMed ID: 1534650
    [TBL] [Abstract][Full Text] [Related]  

  • 67. DNA segments sensitive to single-strand-specific nucleases are present in chromatin of mitotic cells.
    Juan G; Pan W; Darzynkiewicz Z
    Exp Cell Res; 1996 Sep; 227(2):197-202. PubMed ID: 8831556
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Application of real-time fluorescence quantitative PCR accompanied with comparison of Delta CT for diagnosis of Down's syndrome from a single cell].
    Yu R; Chen HP; Yan XF
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Apr; 24(2):200-2. PubMed ID: 17407082
    [TBL] [Abstract][Full Text] [Related]  

  • 69. CD3+/CD30+ circulating T lymphocytes are markedly increased in older subjects with Down's syndrome (Trisomy 21).
    Bertotto A; Crupi S; Fabietti GM; Troiani S; Parente C; Mezzetti D; Vaccaro R
    Pathobiology; 1999; 67(2):108-10. PubMed ID: 10023139
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Possible disorder of tissue immunity function in mothers who have given birth to a child with Down's disease].
    Davidenkova EF; Sokolova SM; Butomo IV; Khitrikova LE; Chukhlovin AB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(6):863-5. PubMed ID: 143174
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The use of propidium iodide in cytochemical studies of interphase chromatin structure.
    Barni S; Gerzeli G
    Basic Appl Histochem; 1985; 29(3):215-30. PubMed ID: 3840680
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparative coherence studies in healthy volunteers and Down's syndrome patients from childhood to adult age.
    Schmid RG; Tirsch WS; Rappelsberger P; Weinmann HM; Pöppl SJ
    Electroencephalogr Clin Neurophysiol; 1992 Aug; 83(2):112-23. PubMed ID: 1378376
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mosaic trisomy 22: a case presentation and literature review of trisomy 22 phenotypes.
    Crowe CA; Schwartz S; Black CJ; Jaswaney V
    Am J Med Genet; 1997 Sep; 71(4):406-13. PubMed ID: 9286446
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Inhibition of Fc gamma receptors in the plasma of subjects with Down's syndrome.
    Guarnotta G; Giardina E; Casiglia D; Rossi C; Accardo-Palumbo A; Triolo G
    Clin Immunol Immunopathol; 1993 Oct; 69(1):92-6. PubMed ID: 8403547
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Changed serum trace element profile in Down's syndrome.
    Kadrabová J; Madáric A; Sustrová M; Ginter E
    Biol Trace Elem Res; 1996 Sep; 54(3):201-6. PubMed ID: 8909693
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Peripheral blood cell counts in infants with Down's syndrome.
    Kivivuori SM; Rajantie J; Siimes MA
    Clin Genet; 1996 Jan; 49(1):15-9. PubMed ID: 8721566
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Reactive oxygen metabolites and prooxidant status in children with Down's syndrome.
    Carratelli M; Porcaro L; Ruscica M; De Simone E; Bertelli AA; Corsi MM
    Int J Clin Pharmacol Res; 2001; 21(2):79-84. PubMed ID: 11824651
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Site and frequency of chromocentres in the interphase nucleus in Down's syndrome and controls.
    Taylor AI
    J Ment Defic Res; 1966 Dec; 10(4):291-2. PubMed ID: 4226453
    [No Abstract]   [Full Text] [Related]  

  • 79. A case of mosaic Down's syndrome concomitant with ganglioneuroma.
    Hosoi H; Sawada T; Nakajima T; Kuroda H; Saida T; Sugimoto T; Tokiwa K; Ogita S
    J Pediatr Surg; 1989 Feb; 24(2):210-1. PubMed ID: 2524564
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Monoclonal antibody-defined B cell subsets in aging humans and Down's syndrome.
    Gupta S; Zola H; Brooks DA; Bradley J; Fikrig SM; Mariano E; Quazi Q
    Gerontology; 1984; 30(6):388-92. PubMed ID: 6240431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.